Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 210

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Network pharmacology to unveil the mechanism of Moluodan in the treatment of chronic atrophic gastritis

Zhou, Wuai, Zhang, Huan, Wang, Xin, Kang, Jun, Guo, Wuyan, Zhou, Lihua, Liu, Huiyun, Wang, Menglei, Jia, Ruikang, Du, Xinjun, Wang, Weihua, Zhang, Bo, Li, Shao · 2022 · Phytomedicine

Abstract

BACKGROUND Moluodan (MLD) is a traditional Chinese patent medicine for the treatment of chronic atrophic gastritis (CAG). However, the mechanism of action (MoA) of MLD for treating CAG still remain unclear. PURPOSE Elucidate the MoA of MLD for treating CAG based on network pharmacology. STUDY DESIGN Integrate computational prediction and experimental validation based on network pharmacology. METHODS Computationally, compounds of MLD were scanned by LC-MS/MS and the target profiles of compounds were identified based on network-based target prediction method. Compounds in MLD were compared with western drugs used for gastritis by hierarchical clustering of target profile. Key biological functional modules of MLD were analyzed, and herb-biological functional module network was constructed to elucidate combinatorial rules of MLD herbs for CAG. Experimentally, MLD's effect on different biological functional modules were validated from both phenotypic level and molecular level in 1- Methyl-3-nitro-1-nitrosoguanidine (MNNG)-induced GES-1 cells. RESULTS Computational results show that the target profiles of compounds in MLD can cover most of the biomolecules reported in literature. The MoA of MLD can cover most types of MoA of western drugs for CAG. The treatment of CAG by MLD involved the regulation of various biological functional modules, e.g., inflammation/immune, cell proliferation, cell apoptosis, cell differentiation, digestion and metabolism. Experimental results show that MLD can inhibit cell proliferation, promote cell apoptosis and differentiation, reduce the inflammation level and promote lipid droplet accumulation in MNNG-induced GES-1 cells. CONCLUSION The network pharmacology framework integrating computational prediction and experimental validation provides a novel way for exploring the MoA of MLD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.phymed.2021.153837

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 210

Metadata

Authors
Zhou, W., Zhang, H., Wang, X., Kang, J., Guo, W., Zhou, L., Liu, H., Wang, M., Jia, R., Du, X., Wang, W., Zhang, B., & Li, S.
Venue
Phytomedicine
Publisher
Elsevier BV
Published
2022-01
Volume
95
Pages
153837
ISSN
0944-7113 (ISSN-L)
OpenAlex
W3212922804
Cited by
210
References
5
FWCI
15.12
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Network pharmacology to unveil the mechanism of Moluodan in the treatment of chronic atrophic gastritis. https://app.cochat.ai/papers/10.1016/j.phymed.2021.153837
The paper
Zhou, W., Zhang, H., Wang, X., Kang, J., Guo, W., Zhou, L., Liu, H., Wang, M., Jia, R., Du, X., Wang, W., Zhang, B., & Li, S. (2022). Network pharmacology to unveil the mechanism of Moluodan in the treatment of chronic atrophic gastritis. Phytomedicine. https://doi.org/10.1016/j.phymed.2021.153837

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.